Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice
The article outlines aspects of the current state of the problem of the priority choice of an oral anticoagulant for indefinite prevention of stroke and systemic thromboembolism in patients with atrial fibrillation. The advantages of direct oral angicoagulants over warfarin are presented, as well as...
Guardado en:
Autores principales: | Marina Yu. Maksimova, Andrei V. Fonyakin, Liudmila A. Geraskina |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
"Consilium Medicum" Publishing house
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/286137aa30ec4ae78394a2f3330bed9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013) -
Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis
por: Dariusz Kotlęga, et al.
Publicado: (2019) -
Transesophageal Echocardiography in Ischemic Stroke With Atrial Fibrillation
por: Kanta Tanaka, et al.
Publicado: (2021) -
Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020) -
The current approach of atrial fibrillation management
por: Anish Amin, et al.
Publicado: (2016)